相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Finite-Size Charged Species Diffusion and pH Change in Nanochannels
Nicola Di Trani et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery
Nicola Di Trani et al.
LAB ON A CHIP (2020)
Management of Immunotherapy-Related Toxicities. Version 1.2019
John A. Thompson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
Hwa Kyung Byun et al.
RADIATION ONCOLOGY (2019)
First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies
Sandra M. M. Irenaeus et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies
Emily Z. Keung et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The Immune Revolution: A Case for Priming, Not Checkpoint
Robert H. Vonderheide
CANCER CELL (2018)
Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer
Corrine Ying Xuan Chua et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Unexpected behaviors in molecular transport through size-controlled nanochannels down to the ultra-nanoscale
Giacomo Bruno et al.
NATURE COMMUNICATIONS (2018)
Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma
Alexander N. Shoushtari et al.
JAMA ONCOLOGY (2018)
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
Ariel E. Marciscano et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank et al.
CANCER DISCOVERY (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity
David A. Knorr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa et al.
NATURE REVIEWS CANCER (2018)
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Claire Vanpouille-Box et al.
CLINICAL CANCER RESEARCH (2018)
Comparison of the Toxicity Profile of PD-1 Versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Analysis of the Literature
Rathi N. Pillai et al.
CANCER (2018)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data
Denis Schapiro et al.
NATURE METHODS (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Intratumoral immunotherapy: using the tumor as the remedy
A. Marabelle et al.
ANNALS OF ONCOLOGY (2017)
Delivering safer immunotherapies for cancer
Lauren Milling et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy
Fang Shi et al.
CANCER BIOLOGY & THERAPY (2017)
Nanochannel Implants for Minimally-Invasive Insertion and Intratumoral Delivery
R. Lyle Hood et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma
Abhijit Ray et al.
ONCOTARGET (2016)
Current clinical trials testing the combination of immunotherapy with radiotherapy
Josephine Kang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors
Sina Moeendarbari et al.
SCIENTIFIC REPORTS (2016)
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria et al.
TRENDS IN CANCER (2016)
Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets
Gabor J. Szebeni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
Riccardo Danielli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Radiotherapy and Immunogenic Cell Death
Encouse B. Golden et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
S. J. Dovedi et al.
ONCOIMMUNOLOGY (2015)
Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary
Paul E. Wallner et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Robotic UV-Vis apparatus for long-term characterization of drug release from nanochannels
T. Geninatti et al.
MEASUREMENT SCIENCE AND TECHNOLOGY (2014)
Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies
Jing Liu et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Emily F. Stamell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Leveraging nanochannels for universal, zero-order drug delivery in vivo
Silvia Ferrati et al.
JOURNAL OF CONTROLLED RELEASE (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
Susan M. Hiniker et al.
TRANSLATIONAL ONCOLOGY (2012)
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Brandon Kwong et al.
BIOMATERIALS (2011)
High Response Rate After Intratumoral Treatment With Interleukin-2 Results From a Phase 2 Study in 51 Patients With Metastasized Melanoma
Benjamin Weide et al.
CANCER (2010)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines
Cory L. Ahonen et al.
BLOOD (2008)
The mouse mammary carcinoma 4T1:: characterization of the cellular landscape of primary tumours and metastatic tumour foci
Sally A. DuPre et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2007)
Specific growth rate versus doubling time for quantitative characterization of tumor growth rate
Esmaeil Mehrara et al.
CANCER RESEARCH (2007)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Locoregional immunotherapy in cancer patients: Review of clinical studies
CML van Herpen et al.
ANNALS OF ONCOLOGY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
